1.Microbiota and Host Interaction:
The Microbiota and Host Interaction study aims to elucidate the complex molecular and cellular mechanisms governing host–microbiome crosstalk in health and disease. It seeks to integrate multi-omics data and computational modelling to uncover how microbial communities influence host metabolism, immunity, and disease progression. The lab focuses on identifying key microbial signatures and functional pathways associated with disorders, including metabolic diseases and inflammatory conditions. Ultimately, it strives to translate these insights into targeted therapeutic strategies and precision medicine approaches.
1a.Genome-scale community metabolic modelling of Human gut microbiota:
Metabolic Flux Analysis (MFA) is an important method for the quantitative estimation of intracellular metabolic flows through metabolic pathways in a variety of cellular metabolism of relevance to medicine and biotechnology. Our current efforts are to identify the altered metabolic profile of the human gut microbiota in different diseases. To achieve this we are constructing the genome-scale metabolic model of human gut microbiota and allowing them to grow in a community. This community model will explore the metabolic interplay and its impact on the biochemical pathway of target cell/tissue.
Beura et al., Scientific Reports, 2024
Kundu 1, Beura 1, Mondal 1 et al., Biotechnology Advances, 2024
Beura et al., Computers in Biology and Medicine, 2022
1b.Tissue/cell-specific Genome-scale metabolic modelling:
Tissue-specific genome-scale modelling is a computational approach used to understand the metabolic behaviour of specific tissues within an organism. It involves tailoring a generic genome-scale metabolic model (GEM) to reflect the metabolic network specific to a given tissue, integrating tissue-specific data such as gene expression, proteomics, and metabolomics. These models can predict metabolic fluxes, understand disease mechanisms, and identify potential therapeutic targets. In our study, we aim to reconstruct the condition-specific model of type 2 diabetic beta cells and compare metabolic alterations with respect to healthy cells.
Beura et al., Biotechnology and Bioengineering, 2026
Beura et al., Biotechnology Journal, 2026
Beura et al., IEEE-iSSSC, 2025
Beura et al., STAR Protocols, 2024
2.Protein Dynamics:
We focus on understanding the relationship between protein structure, function, and dynamics. Research is focused on two major sub-groups: 1) molecular modeling of enzyme-substrate / enzyme-inhibitor interactions and 2) structure-based drug discovery. Studies are performed using computer simulation methods ranging from molecular dynamics simulations, Monte Carlo simulations, and Brownian dynamics simulations. General properties that we address include changes in protein structure and dynamics upon binding inhibitors and with mutations, ligand binding affinity and specificity, and bound water structure.
Beura et al., Journal of Molecular Structure, 2022
Beura et al., Journal of Molecular Structure, 2020
Beura et al., Journal of Biomolecular Structure and Dynamics, 2020
Thank you